Pegaptanib Sodium Patent Expiration
Pegaptanib Sodium is Used for treating VEGF-mediated ocular diseases. It was first introduced by Bausch And Lomb Inc
Pegaptanib Sodium Patents
Given below is the list of patents protecting Pegaptanib Sodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Macugen | US6011020 | Nucleic acid ligand complexes |
Jan 04, 2017
(Expired) | Bausch And Lomb Inc |
| Macugen | US5932462 | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
Aug 03, 2016
(Expired) | Bausch And Lomb Inc |
| Macugen | US6051698 | Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes |
May 19, 2015
(Expired) | Bausch And Lomb Inc |
| Macugen | US5919455 | Non-antigenic branched polymer conjugates |
Oct 27, 2013
(Expired) | Bausch And Lomb Inc |
| Macugen | US6113906 | Water-soluble non-antigenic polymer linkable to biologically active material |
Oct 27, 2013
(Expired) | Bausch And Lomb Inc |
Pegaptanib Sodium's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List